Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $46.08 in the latest trading session, marking a +0.39% move from the prior day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $47.32, moving +0.72% from the previous trading session.
Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots
by Zacks Equity Research
Individuals aged 18 years or older are eligible to avail Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine boosters from Walgreens' (WBA) stores.
Walgreens Boots Alliance (WBA) Stock Moves -0.65%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.22 in the latest trading session, marking a -0.65% move from the prior day.
Walgreens (WBA), VillageMD Plan to Expand Into Tampa, Florida
by Zacks Equity Research
Walgreens (WBA), VillageMD to open 20 new Village Medical at Walgreens primary care practices in the Tampa area to improve access to overall care for patients with chronic conditions.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) given its better-than-expected fourth-quarter fiscal 2021 results and strategic alliances.
Walgreens (WBA) to Make Additional Investment in VillageMD
by Zacks Equity Research
Walgreens (WBA) announced a $5.2-billion investment in VillageMD to bolster its strategic position in delivering value-based primary care.
Ride the Latest Market Rally With These ETFs
by Sweta Jaiswal, FRM
The third-quarter earnings season has begun with a bang, spreading optimism among investors.
NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax
by Zacks Equity Research
Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.
Stock Market News for Oct 15, 2021
by Zacks Equity Research
U.S. stocks ended sharply higher on Thursday after upbeat earnings and better-than expected economic data gave a boost to investors¿¿¿ confidence.
Walgreens (WBA) Hits 300M Milestone With Vitamin Angels
by Zacks Equity Research
Walgreens (WBA) and Vitamin Angels are looking to hit a new goal of reaching 500 million women and children by the end of August 2025.
Walgreens Boots (WBA) Q4 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Walgreens Boots' (WBA) health and wellness sales increase for fiscal Q4 on growing demand for at-home COVID-19 tests and vitamins.
Walgreens Boots Alliance (WBA) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 13.59% and 2.96%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Walgreens (WBA) Ahead of Earnings?
by Zacks Equity Research
Walgreens (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Commercial Metals' (CMC) Q4 Earnings?
by Zacks Equity Research
Commercial Metals' (CMC) Q4 results likely to reflect strong finished steel volumes, driven by solid construction and infrastructure demand.
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens (WBA) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Faster adoption of digital health and an improved business environment are expected to have contributed to Walgreens' (WBA) fourth-quarter performance.
Here's How Investors Can Find Strong Retail and Wholesale Stocks with the Zacks ESP Screener
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Stock Market News for Oct 1, 2021
by Zacks Equity Research
Benchmarks closed in the red on Thursday despite Congress' last-minute move to prevent a partial government shutdown.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.71, marking a +1.29% move from the previous day.
3 High-Potential MedTech Stocks With More Than 50% Growth YTD
by Riya Anand
Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.46, marking a +0.94% move from the previous day.
Here's Why You Should Retain Walgreens (WBA) Stock for Now
by Zacks Equity Research
Investors are optimistic about Walgreens (WBA), given the strong performance in the International segment and notable product launches.
Rite Aid (RAD) to Report Q2 Earnings: What Should You Know?
by Zacks Equity Research
Rite Aid (RAD) is likely to have gained from PBM, RxEvolution strategy and expanded omnichannel services in Q2. Rising wage costs and drab front-end same-store sales are likely to have been concerns.
Walgreens Boots Alliance (WBA) Stock Moves -0.64%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $49.62, moving -0.64% from the previous trading session.